Almirall and Tyris Collaborate to Develop Next Generation Gene Therapies
Shots:
- Tyris to receive up front- research milestone along with research funding and will be responsible for generating clinical lead candidates and will further progress them to clinical development
- Almirall to get an exclusive option to acquire gene therapies and progress them through clinical development to commercialization
- The collaboration will integrate Tyris's non-viral based gene therapy technology and Almirall's expertise in medical dermatology. The alliance will focus on developing next-generation gene therapies with transformational potential for rare genetic dermatology diseases
Ref: PRNewswire | Image: Nature
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com